TABLE 4.
Site | Composition | m/z | z | Glycopeptide |
---|---|---|---|---|
Da | ||||
Asn-11 | GlcNAc1 | 915 | 2 | 1,829 |
Fuc1GlcNAc1 | 988 | 2 | 1,975 | |
(Core)Fuc1 | 1,333 | 2 | 2,665 | |
(Core)Man1 | 1,504 | 2 | 3,007 | |
(Core)Man2 | 1,585 | 2 | 3,169 | |
(Core)Man3 | 1,666 | 2 | 3,331 | |
Asn-124 | GlcNAc1 | 633 | 2 | 1,265 |
(Core)HexNAc1 | 1,078 | 2 | 2,155 | |
(Core)Hex1HexNAc1 | 1,160 | 2 | 2,319 | |
(Core)Hex2HexNAc1 | 1,241 | 2 | 2,481 | |
(Core)Hex2HexNAc2 | 1,342 | 2 | 2,683 | |
(Core)Man2 | 1,139 | 2 | 2,277 | |
(Core)Man3 | 1,220 | 2 | 2,439 | |
(Core)Man4 | 1,301 | 2 | 2,601 | |
(Core)Man5 | 1,382 | 2 | 2,763 | |
(Core)Man6 | 1,463 | 2 | 2,925 | |
(Core)Man7 | 1,544 | 2 | 3,087 | |
(Core)Man8 | 1,625 | 2 | 3,249 | |
Asn-137 | GlcNAc1 | 561 | 2 | 1,121RAsn |
584 | 2 | 1,167Asn | ||
(Core)Fuc1 | 663 | 2 | 1,325RAsn | |
1,002 | 2 | 2,003Asn | ||
(Core)Fuc1HexNAc1 | 720 | 3 | 2,158RAsn | |
1,104 | 2 | 2,207Asn | ||
(Core)Fuc1HexNAc2 | 788 | 3 | 2,362RAsn | |
(Core)Fuc1Hex1HexNAc2 | 856 | 3 | 2,566RAsn | |
1,287 | 2 | 2,573Asn | ||
(Core)Man2 | 911 | 3 | 2,731RAsn | |
1,091 | 2 | 2,181Asn | ||
(Core)Man3 | 780 | 3 | 2,338RAsn | |
1172 | 2 | 2,343Asn | ||
(Core)Man4 | 834 | 3 | 2,501RAsn | |
1,253 | 2 | 2,505Asn | ||
(Core)Man5 | 888 | 3 | 2,662RAsn | |
1,334 | 2 | 2,667Asn | ||
(Core)Man6 | 942 | 3 | 2,770RAsn | |
1,415 | 2 | 2,829Asn | ||
996 | 3 | 2,986RAsn |